World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Chemistry 62 8975 8139 2543 2097 283 11662

John W. Babich publications per year

The chart shows the history of publications by John W. Babich between 1984 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. John W. Babich published across 43 years, from 1984 to 2026, averaging 10.3 papers a year. Output peaked at 24 publications in 2019. 7 of the 444 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1984 to 2026. Vertical axis: number of publications, 0 to 24. Peak 24 publications in 2019. 1984: 2 publications 1985: 0 publications 1986: 2 publications 1987: 1 publication 1988: 7 publications 1989: 3 publications 1990: 2 publications 1991: 8 publications 1992: 9 publications 1993: 10 publications 1994: 9 publications 1995: 7 publications 1996: 11 publications 1997: 6 publications 1998: 14 publications 1999: 5 publications 2000: 18 publications 2001: 14 publications 2002: 7 publications 2003: 5 publications 2004: 10 publications 2005: 13 publications 2006: 9 publications 2007: 13 publications 2008: 20 publications 2009: 21 publications 2010: 16 publications 2011: 11 publications 2012: 21 publications 2013: 14 publications 2014: 14 publications 2015: 13 publications 2016: 15 publications 2017: 15 publications 2018: 17 publications 2019: 24 publications 2020: 20 publications 2021: 12 publications 2022: 5 publications 2023: 8 publications 2024: 6 publications 2025: 6 publications 2026: 1 publication
1984 2026

444 publications in total across all disciplines

View publications per year as a table
John W. Babich: publications per year, 1984 to 2026
Year Publications
1984 2
1985 0
1986 2
1987 1
1988 7
1989 3
1990 2
1991 8
1992 9
1993 10
1994 9
1995 7
1996 11
1997 6
1998 14
1999 5
2000 18
2001 14
2002 7
2003 5
2004 10
2005 13
2006 9
2007 13
2008 20
2009 21
2010 16
2011 11
2012 21
2013 14
2014 14
2015 13
2016 15
2017 15
2018 17
2019 24
2020 20
2021 12
2022 5
2023 8
2024 6
2025 6
2026 1
Total 444
Download as CSV

John W. Babich publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where John W. Babich sits on this spectrum.

No. of scientists
250 500 750 1,000 1,250
Bar chart with 63 bars. Horizontal axis: publications, 61–80 to 1,295+. Vertical axis: number of scientists, 0 to 1,350. Most scientists, 1,350, have 161–180 publications. The last bar groups every scientist with 1,295 publications or more. The highlighted bar, 281–300 publications, is where this scientist sits. 61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61–80 publications 1,295+

This scientist: 283 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

View publications distribution as a table
Number of Chemistry scientists by publication count, Research.com 2026 ranking edition. Based on 17,934 ranked scientists.
Publications Scientists This scientist
61–80 66
81–100 302
101–120 623
121–140 918
141–160 1,218
161–180 1,350
181–200 1,344
201–220 1,281
221–240 1,216
241–260 1,100
261–280 979
281–300 939 283
301–320 764
321–340 643
341–360 628
361–380 522
381–400 459
401–420 397
421–440 327
441–460 270
461–480 265
481–500 252
501–520 201
521–540 185
541–560 148
561–580 148
581–600 132
601–620 114
621–640 104
641–660 91
661–680 92
681–700 73
701–720 57
721–740 54
741–760 67
761–780 45
781–800 46
801–820 39
821–840 32
841–860 36
861–880 29
881–900 26
901–920 24
921–940 14
941–960 23
961–980 28
981–1,000 15
1,001–1,020 29
1,021–1,040 12
1,041–1,060 19
1,061–1,080 12
1,081–1,100 6
1,101–1,120 8
1,121–1,140 12
1,141–1,160 5
1,161–1,180 6
1,181–1,200 14
1,201–1,220 7
1,221–1,240 2
1,241–1,260 6
1,261–1,280 4
1,281–1,294 6
1,295+ 100
Download as CSV

John W. Babich D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where John W. Babich sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 61 bars. Horizontal axis: D-Index, 40–41 to 159+. Vertical axis: number of scientists, 0 to 1,051. Most scientists, 1,051, have 56–57 D-Index. The last bar groups every scientist with 159 D-Index or more. The highlighted bar, 62–63 D-Index, is where this scientist sits. 40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40–41 D-Index 159+

This scientist: 62 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

View D-Index distribution as a table
Number of Chemistry scientists by D-index, Research.com 2026 ranking edition. Based on 17,934 ranked scientists.
D-Index Scientists This scientist
40–41 289
42–43 612
44–45 808
46–47 776
48–49 835
50–51 861
52–53 872
54–55 933
56–57 1,051
58–59 930
60–61 882
62–63 834 62
64–65 731
66–67 775
68–69 683
70–71 646
72–73 561
74–75 501
76–77 437
78–79 388
80–81 354
82–83 292
84–85 275
86–87 254
88–89 235
90–91 185
92–93 192
94–95 155
96–97 163
98–99 125
100–101 105
102–103 105
104–105 112
106–107 88
108–109 68
110–111 69
112–113 65
114–115 79
116–117 61
118–119 44
120–121 37
122–123 40
124–125 33
126–127 26
128–129 34
130–131 35
132–133 25
134–135 27
136–137 17
138–139 16
140–141 20
142–143 20
144–145 15
146–147 9
148–149 9
150–151 16
152–153 11
154–155 9
156–157 3
158 3
159+ 98
Download as CSV

Overview

John W. Babich is affiliated with Cornell University in the United States. Their research primarily spans the field of Medicine, with a focus on subfields including Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Materials Chemistry, and Surgery.

The scientist's work covers several main topics, such as Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research, Medical Imaging Techniques and Applications, Peptidase Inhibition and Analysis, Cardiac Structural Anomalies and Repair, Lanthanide and Transition Metal Complexes, and Cerebrospinal fluid and hydrocephalus.

Frequently publishing venues for John W. Babich include:

  • Journal of Clinical Oncology
  • Research Square (Research Square)
  • Cancer Research
  • Fluids and Barriers of the CNS
  • Translational Oncology

Recent papers authored or coauthored by John W. Babich include:

  • Decreased CSF clearance and increased brain amyloid in Alzheimer's disease, 2022, Fluids and Barriers of the CNS
  • Advances in PSMA theranostics, 2022, Translational Oncology
  • Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for 64Cu/67Cu-Based Theranostics in Prostate Cancer, 2020, Molecular Pharmaceutics
  • Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates, 2020, Human Gene Therapy
  • Phase I study of 225Ac-J591 for men with metastatic castration-resistant prostate cancer (mCRPC), 2021, Journal of Clinical Oncology

Among frequent coauthors collaborating with John W. Babich are:

  • James M. Kelly
  • Anastasia Nikolopoulou
  • Thomas M. Jeitner
  • Joseph R. Osborne
  • Alejandro Amor-Coarasa

Best Publications

  • A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer.

    K. P. Maresca;S. M. Hillier;F. J. Femia;D. Keith

  • Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.

    Shawn M. Hillier;Kevin P. Maresca;Frank J. Femia;John C. Marquis

  • 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer

    Shawn M. Hillier;Kevin P. Maresca;Genliang Lu;Ross D. Merkin

  • A ticket to ride : peptide radiopharmaceuticals

    A J Fischman;J W Babich;H W Strauss

  • Metabolic Imaging With β-Methyl-p-[123I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia

    Vasken Dilsizian;Timothy M. Bateman;Steven R. Bergmann;Roger Des Prez

  • Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer

    Ying Chen;Catherine A. Foss;Youngjoo Byun;Sridhar Nimmagadda

  • An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy

    Nikki A. Thiele;Victoria Brown;James M. Kelly;Alejandro Amor-Coarasa

  • Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.

    Mark Bartholomä;John Valliant;Kevin P. Maresca;John Babich

  • Enhancement of fluid filtration across tumor vessels: Implication for delivery of macromolecules

    Paolo A. Netti;Leena M. Hamberg;John W. Babich;Diane Kierstead

  • Bridging the gap between in vitro and in vivo imaging: isostructural Re and 99mTc complexes for correlating fluorescence and radioimaging studies.

    Karin A. Stephenson;Sangeeta Ray Banerjee;Travis Besanger;Oyebola O. Sogbein

  • Bifunctional single amino acid chelates for labeling of biomolecules with the {Tc(CO)3}+ and {Re(CO)3}+ cores. Crystal and molecular structures of [ReBr(CO)3(H2NCH2 C5H4N)], [Re(CO)3{(C5H4 NCH2)2NH}]Br,

    Sangeeta Ray Banerjee;Murali K. Levadala;Neva Lazarova;Lihui Wei

  • New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.

    Sangeeta Ray Banerjee;Kevin P. Maresca;Lynn Francesconi;John Valliant

  • A convenient synthesis, chemical characterization and reactivity of [Re(CO)3(H2O)3]Br: the crystal and molecular structure of [Re(CO)3(CH3CN)2Br]

    Neva Lazarova;Shelly James;John Babich;Jon Zubieta

  • PSMA as a target for radiolabelled small molecules

    Matthias Eder;Michael Eisenhut;John Babich;Uwe Haberkorn

  • Glu-Ureido-Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers.

    Klaus Kopka;Martina Benešová;Cyril Bařinka;Uwe Haberkorn

  • A new strategy for the preparation of peptide-targeted radiopharmaceuticals based on an fmoc-lysine-derived single amino acid chelate (SAAC). automated solid-phase synthesis, NMR characterization, and in vitro screening of fMLF(SAAC)G and fMLF[(SAAC-Re(CO)3)+]G.

    Karin A Stephenson;Jon Zubieta;Sangeeta Ray Banerjee;Murali K Levadala

  • Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma.

    R. J. Ott;M. Brada;M. A. Flower;J. W. Babich

  • Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection.

    John W. Babich;Howard Solomon;Marilyn C. Pike;Daniel Kroon

  • Rapid detection of Parkinson's disease by SPECT with altropane: A selective ligand for dopamine transporters

    Alan J. Fischman;Ali A. Bonab;John W. Babich;E. Prather Palmer

  • Effect of “co-ligand” on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides

    J.W. Babich;A.J. Fischman

  • Synthesis and Characterization of Organohydrazino Complexes of Technetium, Rhenium, and Molybdenum with the {M(η1-HxNNR)(η2-HyNNR)} Core and Their Relationship to Radiolabeled Organohydrazine-Derivatized Chemotactic Peptides with Diagnostic Applications

    David J. Rose;Kevin P. Maresca;Terrence Nicholson;Alan Davison

Frequent Co-Authors

Jon Zubieta
Jon Zubieta Syracuse University
Alan J. Fischman
Alan J. Fischman Harvard University
Robert H. Rubin
Robert H. Rubin Brigham and Women's Hospital
Nathaniel M. Alpert
Nathaniel M. Alpert Harvard University
Uwe Haberkorn
Uwe Haberkorn Heidelberg University
Stanley J. Goldsmith
Stanley J. Goldsmith Cornell University
Neil H. Bander
Neil H. Bander Cornell University
Ronald G. Tompkins
Ronald G. Tompkins Harvard University
David M. Nanus
David M. Nanus Cornell University
Walter Mier
Walter Mier University Hospital Heidelberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a Chemistry degree in the USA opens doors to diverse career opportunities, particularly in the pharmaceutical and forensic science fields. Many students consider transitioning to roles such as pharmaceutical sales representatives, where understanding chemistry enhances product knowledge and client trust. Curious about compensation? Discover how much do pharmaceutical sales reps make to better evaluate this path.

Alternatively, if you are interested in healthcare, becoming a pharmacist is a rewarding option. The journey requires commitment and education; learn more about how long does it take to become a pharmacist before making this decision.

For those fascinated by forensic investigations, becoming an autopsy technician is a critical role that combines scientific knowledge and meticulous attention to detail. Check out the earning potential by exploring how much do autopsy techs make. Moreover, if affordability is a concern, you can consider enrolling in the cheapest online forensic science degree programs available, which provide flexible and cost-effective education options.

Exploring these related online degrees and career pathways can help Chemistry students align their passion with practical career goals while making informed decisions about education and job prospects.

Best Scientists Citing John W. Babich

Trending Scientists

Recently Published Articles